Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Lung Neoplasms × Genistein × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urinary Bladder Neoplasms 2 Breast Neoplasms 2 Wilms Tumor 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Lung Neoplasms 1 Hodgkin Disease 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1

Interventions

Carboplatin 89 Pemetrexed 65 Paclitaxel 50 Erlotinib Hydrochloride 46 Cisplatin 46 Radiotherapy 45 Docetaxel 37 Gemcitabine 34 Bevacizumab 32 pembrolizumab 25 Nivolumab 23 Radiosurgery 18 Etoposide 18 durvalumab 12 Cetuximab 12 Ipilimumab 11 Albumin-Bound Paclitaxel 10 Vinorelbine 9 Taxes 9 Gefitinib 9 Radiation 8 Magnetic Resonance Spectroscopy 8 osimertinib 7 Specimen Handling 7 Platinum 7 Cyclophosphamide 7 Biopsy 7 130-nm albumin-bound paclitaxel 7 vandetanib 6 epacadostat 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02567799 2024-01-25

NSCLC

Humanetics Corporation

Phase 1/2 Completed

21 enrolled 32 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡